In addition, accumulating evidence indicates that TTK is related to poor prognosis and malignant progression in gastric cancer [8], colon cancer [9], clear cell renal cell carcinoma [10], prostate cancer [11], breast cancer [12, 13], non-small-cell lung cancer [14], and medulloblastoma [15]. This evidence concerns the gene TTK and breast carcinoma.